Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $16.41 million. The enterprise value is $13.03 million.

Market Cap	16.41M
Enterprise Value	13.03M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

CVKD has 3.08 million shares outstanding. The number of shares has increased by 63.48% in one year.

Current Share Class	3.08M
Shares Outstanding	3.08M
Shares Change (YoY)	+63.48%
Shares Change (QoQ)	+3.86%
Owned by Insiders (%)	16.99%
Owned by Institutions (%)	6.56%
Float	2.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.87
P/TBV Ratio	6.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.72

Current Ratio	2.72
Quick Ratio	2.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -260.11% and return on invested capital (ROIC) is -165.32%.

Return on Equity (ROE)	-260.11%
Return on Assets (ROA)	-116.44%
Return on Invested Capital (ROIC)	-165.32%
Return on Capital Employed (ROCE)	-491.51%
Weighted Average Cost of Capital (WACC)	12.80%
Revenue Per Employee	n/a
Profits Per Employee	-$3.31M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.27% in the last 52 weeks. The beta is 1.55, so CVKD's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-68.27%
50-Day Moving Average	6.24
200-Day Moving Average	9.69
Relative Strength Index (RSI)	47.13
Average Volume (20 Days)	47,302

Short Selling Information

The latest short interest is 43,509, so 1.41% of the outstanding shares have been sold short.

Short Interest	43,509
Short Previous Month	29,406
Short % of Shares Out	1.41%
Short % of Float	1.70%
Short Ratio (days to cover)	1.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.46M
Pretax Income	-13.24M
Net Income	-13.24M
EBITDA	-13.45M
EBIT	-13.46M
Earnings Per Share (EPS)	-$6.64

Full Income Statement

Balance Sheet

The company has $4.01 million in cash and n/a in debt, giving a net cash position of $4.01 million or $1.30 per share.

Cash & Cash Equivalents	4.01M
Total Debt	n/a
Net Cash	4.01M
Net Cash Per Share	$1.30
Equity (Book Value)	2.74M
Book Value Per Share	1.17
Working Capital	2.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.60 million and capital expenditures -$5,104, giving a free cash flow of -$12.61 million.

Operating Cash Flow	-12.60M
Capital Expenditures	-5,104
Depreciation & Amortization	6,874
Net Borrowing	n/a
Free Cash Flow	-12.61M
FCF Per Share	-$4.10

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-63.48%
Shareholder Yield	-63.48%
Earnings Yield	-77.69%
FCF Yield	-73.99%

Analyst Forecast

The average price target for CVKD is $13.00, which is 143.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	143.90%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1